Highlights from the Virtual Clinical Science Summit 2021
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Top talks and new resources detailing key developments in the fields of clinical research and diagnostics are now available on demand
Catch up on this on-demand webinar to discover how combining multiplexing with HTS could streamline your drug discovery
The self-collection kits facilitate raw saliva collection to aid global SARS-CoV-2 research and surveillance efforts
In this guest editorial, Michaël van der Jagt, CEO of Parx Materials, discusses how the human immune system can inspire innovation
The clinical data for Avacta’s AffiDX SARS-CoV-2 antigen lateral flow test demonstrated 100% sensitivity
The Panbio self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology
The facility will be capable of manufacturing batches ranging from those for early-stage research to GMP for clinical and future commercial uses
This open access tool, powered by data supplied by GISAID, provides virologists and COVID-19 test developers insight to the latest viral variants and primer designs used around the world
Scientific, technological and communications excellence has been celebrated at the Clinical Science Summit, with Beckman Coulter, Zymo Research, and PerkinElmer among those recognized
Watch this on-demand webinar to discover a new approach to profiling antibody responses by quantifying affinity and concentration
The drug candidate was associated with a reduction in the need for supplemental oxygen support, earlier time to discharge from hospital and was well tolerated
Learn about the large scale COVID-19 PCR testing program set up by the government of Luxembourg
Updated version of highly sensitive and accurate COVID-19 PCR kit accounts for known and future viral mutations
Learn more about the efficient and reproducible multiplex immunoassays set to change the way COVID-19 researchers profile antibody response